Clinical News
Ovarian Cancer News
Maintenance Therapy with Votrient Provides Benefit in Advanced Ovarian Cancer (June 13, 2013)In a Phase III clinical trial, treatment with Votrient® (pazopanib) after initial chemotherapy improved outcomes among women with advanced ovarian cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology... Continue Reading
Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading
Delaying Chemotherapy Increases Mortality in Ovarian Cancer (April 12, 2013)Women with advanced ovarian cancer have significantly worse survival when they wait more than 25 days after surgery to start chemotherapy, according to the results of a study presented at the 2013 Society of Gynecologic Oncology Annual Meeting on Women’s... Continue Reading
Cancer Deaths on the Decline (February 11, 2013)Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
Aspirin May Reduce Risk of Serous Ovarian Cancer (October 18, 2012)Women who regularly use aspirin may have a decreased risk of developing serous ovarian cancer, according to the results of a study published in Acta Obstetricia et Gynecologica Scandinavica. Ovarian cancer has the highest mortality rate of all gynecologic... Continue Reading
Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading
Latest Ovarian Cancer News By Stage
Recurrent Ovarian Cancer
Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)
A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading
More Recurrent Ovarian CancerScreening/Prevention Ovarian Cancer
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)
The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Aspirin May Reduce Risk of Serous Ovarian Cancer (October 18, 2012)Women who regularly use aspirin may have a decreased risk of developing serous ovarian cancer, according to the results of a study published in Acta Obstetricia et Gynecologica Scandinavica. Ovarian cancer has the highest mortality rate of all gynecologic... Continue Reading
Healthy Women Need Not Undergo Screening for Ovarian Cancer (April 19, 2012)Healthy women at average risk for ovarian cancer do not need to get screened for the disease, according to the U.S. Preventive Services Task Force (USPSTF). After a recent review of the data, the government panel has renewed its 2004 recommendation against... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
More Screening/Prevention Ovarian CancerStage I Ovarian Cancer
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)
The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading
BRCA Genes May Influence Ovarian Cancer Outcomes (October 24, 2011)Among women with ovarian cancer, those who have a BRCA2 gene mutation may have a better response to chemotherapy and longer survival than those who do not have a BRCA gene mutation. These results were published in the Journal of the American Medical Association. Inherited... Continue Reading
More Stage I Ovarian CancerStage II-IV Ovarian Cancer
Maintenance Therapy with Votrient Provides Benefit in Advanced Ovarian Cancer (June 13, 2013)
In a Phase III clinical trial, treatment with Votrient® (pazopanib) after initial chemotherapy improved outcomes among women with advanced ovarian cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology... Continue Reading
Delaying Chemotherapy Increases Mortality in Ovarian Cancer (April 12, 2013)Women with advanced ovarian cancer have significantly worse survival when they wait more than 25 days after surgery to start chemotherapy, according to the results of a study presented at the 2013 Society of Gynecologic Oncology Annual Meeting on Women’s... Continue Reading
Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading
Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading
Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading
More Stage II-IV Ovarian Cancer